دورية أكاديمية

Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer.

التفاصيل البيبلوغرافية
العنوان: Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer.
المؤلفون: KOICHI YAMADA, NORIHISA MASAI, DAISAKU TATSUMI, HIROYA SHIOMI, RYOONG‑JIN OH, HIROSHI DOI, KENJI UEMOTO, OSAMU SUZUKI
المصدر: Oncology Letters; Jul2017, Vol. 14 Issue 1, p453-460, 8p, 3 Charts, 2 Graphs
مصطلحات موضوعية: COLON cancer diagnosis, METASTASIS, CANCER treatment, RADIOTHERAPY, CARRIER proteins, NEOPLASTIC cell transformation
مستخلص: Metastatic liver tumors (MLTs) from colorectal cancer (CRC) are often treated with stereotactic body radiation therapy (SBRT). The present study aimed to examine the predictive factors for response of MLTs to SBRT. A total of 39 MLTs from 24 patients with CRC were retrospectively analyzed. Radiotherapy for MLT was typically performed with a prescribed dose equivalent to a biologically effective dose (BED)10 of 100 Gy. The median follow‑up period was 16 months (range, 5‑64 months). The median prescribed dose and total BED10 were 56 Gy (range, 45‑72 Gy) and 97.5 Gy (range, 71.7‑115.5 Gy), respectively, in a median of 8 fractions (range, 4‑33 fractions). The 1‑ and 2‑year local control rates were 67.2 and 35.9%, respectively. For patients with MLT treated with ablative SBRT (BED10 ≥100 Gy in ≤5 fractions), the 1‑ and 2‑year local control rates were 83.3 and 62.5%, respectively. Univariate analysis showed that primary tumor location (left‑sided colon), maximum tumor diameter (≤30 mm) and ablative SBRT (BED10 ≥100 Gy in ≤5 fractions) were significantly associated with improved local control (P=0.0058, P=0.0059 and P=0.0268, respectively). Multivariate analysis showed that tumor diameter was significantly associated with improved local control (P=0.0314). In addition, patients who received ablative SBRT had significantly prolonged overall survival times compared with those treated with non‑ablative SBRT (P=0.0261). To conclude, tumors ≤30 mm that can be treated with ablative SBRT are associated with good local control rates. The primary tumor location may affect the radiosensitivity of MLTs. [ABSTRACT FROM AUTHOR]
Copyright of Oncology Letters is the property of Spandidos Publications UK Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17921074
DOI:10.3892/ol.2017.6167